Blinklab Commences Partnership with Turning Pointe Autism Foundation for Clinical Study in Children with Autism in the US SmartNews
Galecto Announces First Patient Dosed in an Investigator-Initiated Phase 2 Trial of GB1211 in Combination with Pembrolizumab Life Science Investing
Aligos Therapeutics to Announce 1st Quarter 2024 Financial Results on May 7, 2024 Life Science Investing
ARS Pharmaceuticals Submits Response for neffy® Marketing Authorization Application to EMA's CHMP and Enters License Agreement with CSL Seqirus for Commercialization of neffy in Australia and New Zealand Life Science Investing
Quarterly Activities Report: Melodiol Delivers $4.4M in Revenue during Q1 FY24 – a 91% Increase the PCP Psychedelics Investing
